A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
Lee, J K, Capanu, M, O'Reilly, E M, Ma, J, Chou, J F, Shia, J, Katz, S S, Gansukh, B, Reidy-Lagunes, D, Segal, N H, Yu, K H, Chung, K-Y, Saltz, L B, Abou-Alfa, G K
Published in British journal of cancer (20.08.2013)
Published in British journal of cancer (20.08.2013)
Get full text
Journal Article
Outcome of patients with fibrolamellar hepatocellular carcinoma
Stipa, Francesco, Yoon, Sam S., Liau, Kui Hin, Fong, Yuman, Jarnagin, William R., D'Angelica, Michael, Abou‐Alfa, G., Blumgart, Leslie H., DeMatteo, Ronald P.
Published in Cancer (15.03.2006)
Published in Cancer (15.03.2006)
Get full text
Journal Article
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Ducreux, M., Abou-Alfa, G.K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J.M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., O’Connor, J.-M., O’Reilly, E.M., Osterlund, P., Philip, P., Prager, G., Ruiz-Garcia, E., Sangro, B., Seufferlein, T., Tabernero, J., Verslype, C., Wasan, H., Van Cutsem, E.
Published in ESMO open (01.06.2023)
Published in ESMO open (01.06.2023)
Get full text
Journal Article
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
Abou-Alfa, G.K., Qin, S., Ryoo, B.-Y., Lu, S.-N., Yen, C.-J., Feng, Y.-H., Lim, H.Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W.P., Chen, Z., Hubner, R.A., Meyer, T., Sun, W., Harding, J.J., Hollywood, E.M., Ma, J., Wan, P.J., Ly, M., Bomalaski, J., Johnston, A., Lin, C.-C., Chao, Y., Chen, L.-T.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
Duffy, A., Capanu, M., Abou-Alfa, G.K., Huitzil, D., Jarnagin, W., Fong, Y., D'Angelica, M., DeMatteo, R.P., Blumgart, L.H., O'Reilly, E.M.
Published in Journal of surgical oncology (01.12.2008)
Published in Journal of surgical oncology (01.12.2008)
Get full text
Journal Article
Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations
Hollebecque, A., Borad, M., Sahai, V., Catenacci, D.V.T., Murphy, A., Vaccaro, G., Paulson, A., Oh, D.-Y., Féliz, L., Lihou, C., Zhen, H., Abou-Alfa, G.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Miksad, R., Cicin, I., Chen, Y., Klumpen, H., Kim, S., Lin, Z., Youkstetter, J., Sen, S., Cheng, A., Meyer, T., Kelley, R., Abou-Alfa, G.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF trial
Javle, M., Borbath, I., Clarke, S., Hitre, E., Louvet, C., Macarulla, T., Oh, D., Spratlin, J., Valle, J., Weiss, K., Berman, C., Howland, M., Ye, Y., Cho, T., Moran, S., Abou-Alfa, G.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)
Kelley, R.K., El-Khoueiry, A.B., Meyer, T., Rimassa, L., Merle, P., Chan, S.L., Tran, A., Parnis, F., Tam, V.C., Cattan, S., Markby, D.W., Clary, D.O., Cheng, A.-L., Abou-Alfa, G.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
Merle, P., Rimassa, L., Ryoo, B., Cicin, I., Harris, W., Banu, E., Sarker, D., Tan, B., Van Vlierberghe, H., Sen, S., Love, C., Cheng, A., Meyer, T., Kelley, R., Abou-Alfa, G.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress
Cheng, A., Abou-Alfa, G., Ren, Z., Assenat, E., Cubillo, A., Pluntke, S., Rimassa, L., Ross, P., Wyrwicz, L., Hou, J., Li, C., Wu, J., Ducreux, M.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
Blanc, J.F., Meyer, T., Cheng, A.-L., El-Khoueiry, A.B., Cicin, I., Chen, Y., Bolondi, L., Dadduzio, V., Baron, A., Lin, Z.-Z., Adriani, J., Kelly, R.K., Abou-Alfa, G.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
Yau, T., Merle, P., Rimassa, L., Ryoo, B.-Y., Cicin, I., Harris, W.P., Banu, E., Sarker, D., Tan, B., van Vlierberghe, H., Sen, S., Love, C., Cheng, A.-L., Meyer, T., Kelley, R.K., Abou-Alfa, G.K.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer
Oh, D.-Y., Park, J.-O., Charoentum, C., Stein, S., Noel, M., Chung, V., Wu, W., Alton, R., Muhsin, M., Javle, M., Abou-Alfa, G.K., Borad, M.J.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Yau, T., Cheng, A.-L., Meyer, T., Ryoo, B.-Y., Park, J.-W., Klümpen, H.-J., Lim, H.Y., Kim, S., Knox, J., Patel, M., El-Khoueiry, A.B., Kelley, R.K., Abou-Alfa, G.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
Javle, M., Kelley, R.K., Roychowdhury, S., Weiss, K.H., Abou-Alfa, G.K., Macarulla, T., Sadeghi, S., Waldschmidt, D., Zhu, A.X., Goyal, L., Borad, M., Yong, W.P., Borbath, I., El-Khoueiry, A., Philip, P., Moran, S., Ye, Y., Ising, M., Lewis, N., Bekaii-Saab, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients
Do, R K G, McErlean, A, Ang, C S, DeMatteo, R P, Abou-Alfa, G K
Published in British journal of radiology (01.08.2014)
Published in British journal of radiology (01.08.2014)
Get full text
Journal Article
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202
Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G.M., Melisi, D., Al Rajabi, R.M., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Veronese, M.L., Abou-Alfa, G.K.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article